type here...

CATEGORIES

Pharmaceutics

LATEST

1...789...11Page 8 of 11

TRENDING

EDITORS CHOICE

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

Medika Life -
CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

Lilly commits Insulin Value Program, With $35 Copay Card

Medika Life -
Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.

Ten Facts You Didn’t Know About Moderna and Their mRNA Vaccine

Robert Turner, Founding Editor -
Ten little know facts about Moderna Inc. and its interesting climb to pharmaceutical fame, driven by a man who does not compromise, Stephane Bancel

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Robert Turner, Founding Editor -
Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories